Medtronic to announce financial results for its first quarter of fiscal year 2026
Medtronic (NYSE:MDT), the global healthcare technology leader, has scheduled its fiscal year 2026 first quarter financial results announcement for Tuesday, August 19, 2025. The results will cover the period ending July 25, 2025.
The company will release its financial summary at 5:45 a.m. CDT, followed by a video webcast at 7:00 a.m. CDT. Medtronic has also announced the reporting dates for the remaining quarters of FY2026: November 18, 2025 (Q2), February 17, 2026 (Q3), and May 20, 2026 (Q4).
Medtronic (NYSE:MDT), leader mondiale nella tecnologia sanitaria, ha programmato l'annuncio dei risultati finanziari del primo trimestre dell'anno fiscale 2026 per martedì 19 agosto 2025. I risultati riguarderanno il periodo terminato il 25 luglio 2025.
L'azienda pubblicherà il riepilogo finanziario alle 5:45 a.m. CDT, seguito da una trasmissione video in diretta alle 7:00 a.m. CDT. Medtronic ha inoltre comunicato le date di pubblicazione dei risultati per i restanti trimestri del FY2026: 18 novembre 2025 (Q2), 17 febbraio 2026 (Q3) e 20 maggio 2026 (Q4).
Medtronic (NYSE:MDT), líder global en tecnología sanitaria, ha programado el anuncio de sus resultados financieros del primer trimestre del año fiscal 2026 para el martes 19 de agosto de 2025. Los resultados cubrirán el período que finaliza el 25 de julio de 2025.
La compañía publicará su resumen financiero a las 5:45 a.m. CDT, seguido de una transmisión en video a las 7:00 a.m. CDT. Medtronic también ha anunciado las fechas de reporte para los trimestres restantes del FY2026: 18 de noviembre de 2025 (Q2), 17 de febrero de 2026 (Q3) y 20 de mayo de 2026 (Q4).
Medtronic (NYSE:MDT), 글로벌 헬스케� 기술 선도 기업� 2026 회계연도 1분기 재무 실적 발표� 2025� 8� 19� 화요�� 예정했습니다. 실적은 2025� 7� 25� 종료되는 기간� 포함합니�.
사� 중부 표준�(CDT) 오전 5� 45�� 재무 요약� 발표하고, 이어� 중부 표준�(CDT) 오전 7�� 비디� 웹캐스트� 진행� 예정입니�. Medtronic은 또한 2026 회계연도 남은 분기 실적 발표 일정� 다음� 같이 발표했습니다: 2025� 11� 18� (2분기), 2026� 2� 17� (3분기), 2026� 5� 20� (4분기).
Medtronic (NYSE:MDT), leader mondial des technologies de santé, a programmé l'annonce de ses résultats financiers du premier trimestre de l'exercice 2026 pour le mardi 19 août 2025. Les résultats couvriront la période se terminant le 25 juillet 2025.
La société publiera son résumé financier à 5h45 CDT, suivi d'une webdiffusion vidéo à 7h00 CDT. Medtronic a également annoncé les dates de publication pour les trimestres restants de l'exercice 2026 : 18 novembre 2025 (T2), 17 février 2026 (T3) et 20 mai 2026 (T4).
Medtronic (NYSE:MDT), der weltweit führende Anbieter von Medizintechnik, hat die Bekanntgabe der Finanzergebnisse ü das erste Quartal des Geschäftsjahres 2026 ü Dienstag, den 19. August 2025 geplant. Die Ergebnisse beziehen sich auf den Zeitraum bis zum 25. Juli 2025.
Das Unternehmen wird die Finanzübersicht um 5:45 Uhr CDT veröffentlichen, gefolgt von einem Video-Webcast um 7:00 Uhr CDT. Medtronic hat außerdem die Berichtstermine ü die verbleibenden Quartale des Geschäftsjahres 2026 bekanntgegeben: 18. November 2025 (Q2), 17. Februar 2026 (Q3) und 20. Mai 2026 (Q4).
- None.
- None.
- A news release containing summary financial information will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at
- A video webcast to discuss results will begin at 7:00 a.m. CDT and can be accessed at
- Within 24 hours of the video webcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at .
Looking ahead, Medtronic plans to report its fiscal year 2026 second, third, and fourth quarter results on Tuesday, November 18, 2025, February 17, 2026, and Wednesday, May 20, 2026, respectively. Confirmation and additional details will be provided closer to the specific event.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts:
Erika Winkels
Public Relations
+1-763-526-8478
ⲹ±ڱԲԾԲ
Investor Relations
+1-763-505-4626
View original content to download multimedia:
SOURCE Medtronic plc